10-Q Filing

REGENXBIO INC. CIK: 1590877 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0001564590-18-011844`
Period End Date	20180331
Filing Date	20180508
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	rgnx-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 39 Cash Flow Statement 57

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.66M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$71.87M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$114.12M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$158.00M	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$473.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$25.98M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$5.33M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.67M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.41M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.30M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.21M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.90M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$262.72M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.90M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.30M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$168.00M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$15.62M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$5.92M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetNoncurrent`	$32.65M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$14.83M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.98M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$225.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$225.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$862.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$883.00K	USD	Point-in-time
Total assets	`Assets`	$317.22M	USD	Point-in-time
Total assets	`Assets`	$198.68M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.83M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.01M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$9.61M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$9.87M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.88M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.21M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.23M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.78M	USD	Point-in-time
Total liabilities	`Liabilities`	$17.88M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.65M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2018 and December 31, 2017	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2018 and December 31, 2017	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2018 and December 31, 2017; 31,900 and 31,295 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2018 and December 31, 2017; 31,900 and 31,295 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$371.50M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$378.95M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-903.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-715.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-187.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-78.71M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$299.34M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$183.03M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$198.68M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$317.22M	USD	Point-in-time

Income Statement 39 line items

Line Item	Tag	Value	Unit	Period
License revenue	`LicensesRevenue`	$132.39M	USD	1 Quarter
License revenue	`LicensesRevenue`	$455.00K	USD	1 Quarter
Total revenues	`Revenues`	$132.39M	USD	1 Quarter
Total revenues	`Revenues`	$455.00K	USD	1 Quarter
Licensing costs	`LicenseCosts`	$2.41M	USD	1 Quarter
Licensing costs	`LicenseCosts`	$91.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$16.62M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$19.55M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.38M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.62M	USD	1 Quarter
Other operating expenses	`OtherOperatingIncomeExpenseNet`	$-28.00K	USD	1 Quarter
Other operating expenses	`OtherOperatingIncomeExpenseNet`	$-45.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$30.37M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$23.38M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$102.03M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-22.92M	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$1.35M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$859.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$929.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.21M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$929.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$104.24M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-21.99M	USD	1 Quarter
Unrealized loss on available-for-sale securities, net of reclassifications and income tax expense	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-188.00K	USD	1 Quarter
Unrealized loss on available-for-sale securities, net of reclassifications and income tax expense	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-539.00K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-539.00K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-188.00K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-22.53M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$104.05M	USD	1 Quarter
Net income (loss) applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-21.99M	USD	1 Quarter
Net income (loss) applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$104.24M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.82	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$3.30	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.82	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$3.04	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	26.67M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	31.63M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	26.67M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	34.27M	shares	1 Quarter

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$104.24M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-21.99M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$2.59M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$3.29M	USD	1 Quarter
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-469.00K	USD	1 Quarter
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-378.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$554.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$834.00K	USD	1 Quarter
Net realized gains on sales of marketable securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$480.00K	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$1.35M	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-10.00K	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-41.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-803.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$51.41M	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$68.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-667.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$446.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-88.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-10.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$21.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$2.47M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$477.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$490.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-1.92M	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$-44.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$27.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$957.00K	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-17.48M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$58.13M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$5.19M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$54.27M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$19.52M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$10.50M	USD	1 Quarter
Sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$780.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.93M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.34M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$3.16M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-37.09M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$161.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$3.82M	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$342.00K	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$147.00K	USD	1 Quarter
Proceeds from public offering of common stock, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStock`	$71.30M	USD	1 Quarter
Issuance costs for public offering of common stock	`PaymentsOfStockIssuanceCosts`	$84.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$71.52M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$4.17M	USD	1 Quarter
Net increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$57.20M	USD	1 Quarter
Net increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$25.21M	USD	1 Quarter
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.07M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.27M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.88M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.09M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.07M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.27M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.88M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.09M	USD	Point-in-time
Issuance costs for public offering of common stock in accounts payable and accrued expenses	`IssuanceCostsForPublicOfferingOfCommonStockInAccountsPayableAndAccruedExpenses`	$328.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.